Has Colin Hinkamp received payments from drug or device companies?

Yes. Drug and device makers reported $10,918 in general payments to Colin Hinkamp across 169 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Colin Hinkamp did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Colin Hinkamp come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Colin Hinkamp

Cardiovascular Disease · Houston, TXNPI 1609379411

Payments from drug & device makers

$10,918in general payments, 2019–2025

Across 169 payments — averaging $64.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Boston Scientific$2K
Abiomed$833
Actelion Pharmaceuticals US, Inc.$612
Inari Medical, Inc.$342
Medtronic$334
plus $3K from 28 others

What the payments were for

Speaking & faculty fees$280%
Grants$2002%
Travel & lodging$1,80617%
Food & beverage$8,39577%
Education$4894%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	38	$3,676
Boston Scientific	24	$1,819
Abiomed	14	$833
Actelion Pharmaceuticals US, Inc.	14	$612
Inari Medical, Inc.	2	$342
Medtronic	6	$334
Bridgebio Pharma, Inc.	6	$320
Amgen	11	$297
Cook Medical LLC	4	$284
Teleflex LLC	2	$265
Cardiva Medical, Inc.	6	$248
Cook Incorporated	1	$200
Angiodynamics, Inc.	1	$197
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$168
Bard Peripheral Vascular, Inc.	2	$158
Livanova USA, Inc.	1	$152
Pulmonx Corporation	1	$146
Saranas, Inc.	1	$143
Novartis	5	$115
BD	4	$112
Edwards Lifesciences	5	$102
Cvrx, Inc.	2	$57
Endotronix, Inc.	1	$45
Cordis US CORP.	2	$45
Impulse Dynamics (USA) Inc.	1	$45
Kiniksa Pharmaceuticals International, PLC	1	$33
Lexicon Pharmaceuticals, Inc.	1	$27
Boehringer Ingelheim	1	$27
Esperion Therapeutics, Inc.	1	$24
Kiniksa Pharmaceuticals, Ltd.	1	$22
AstraZeneca	1	$20
W. L. Gore & Associates, Inc.	1	$19
Heartflow, Inc.	1	$17
Nxstage Medical, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,918 in reported general payments places this provider in the 70th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas →

Other cardiovascular disease in Houston

Christie BallantyneHouston$4.6M
Syed NaqviHouston$3.6M
James FeldmanHouston$3.1M
Aditya SamalHouston$2.6M
Pranav LoyalkaHouston$2.4M
Anwar AhmadHouston$1.4M
Reynolds DelgadoHouston$1.1M
Richard SmallingHouston$908K
Amin KarimHouston$853K
Stephen LittleHouston$806K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →